Keywords
Last Name
Institution

Julianne C. Flanagan

Title
InstitutionMedical University of South Carolina
DepartmentPsychiatry and Behavioral Sciences
AddressP.O. Box MSC 861
Suite 151
Charleston Center - 5 Charleston Center Drive, Cha
Phone843-792-5569
Fax843-792-5932
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Flanagan's program of research focuses on the relationships between post-traumatic stress disorder, substance use disorders, and interpersonal violence. She is currently conducting laboratory and treatment development studies aimed at better understanding behavioral and neurobiological underpinnings of violence among individuals and couples. She is also conducting studies examining behavioral and pharmacological interventions to mitigate these commonly co-occurring problems. Dr. Flanagan has received training support from NIAAA, NIDA, and NICHD/ORWH.

    Collapse keywords
    Drug Studies, Psychiatry, Healthy Volunteer Studies, Substance Use, Mental Health, Stress Disorders, Alcohol, PTSD, interpersonal violence, treatment development, oxytocin

    Collapse ORNG Applications 
    Collapse studies/trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Flanagan JC, Sippel LM, Santa Maria MMM, Hartwell KJ, Brady KT, Joseph JE. Impact of Oxytocin on the neural correlates of fearful face processing in PTSD related to childhood Trauma. Eur J Psychotraumatol. 2019; 10(1):1606626. PMID: 31105906.
      View in: PubMed
    2. Flanagan JC, Joseph JE, Nietert PJ, Back SE, McCrady BS. Design of a randomized controlled trial examining the efficacy of oxytocin to enhance alcohol behavioral couple therapy. Contemp Clin Trials. 2019 Jul; 82:1-8. PMID: 31063869.
      View in: PubMed
    3. Jeffirs SM, Jarnecke AM, Flanagan JC, Killeen TK, Laffey TF, Back SE. Veterans with PTSD and comorbid substance use disorders: Does single versus poly-substance use disorder affect treatment outcomes? Drug Alcohol Depend. 2019 Jun 01; 199:70-75. PMID: 31009834.
      View in: PubMed
    4. Gilmore AK, Flanagan JC. Acute mental health symptoms among individuals receiving a sexual assault medical forensic exam: the role of previous intimate partner violence victimization. Arch Womens Ment Health. 2019 Feb 14. PMID: 30762148.
      View in: PubMed
    5. Flanagan JC, Yonce S, Calhoun CD, Back SE, Brady KT, Joseph JE. Preliminary development of a neuroimaging paradigm to examine neural correlates of relationship conflict. Psychiatry Res Neuroimaging. 2019 Jan 30; 283:125-134. PMID: 30581042.
      View in: PubMed
    6. Back SE, Killeen T, Badour CL, Flanagan JC, Allan NP, Ana ES, Lozano B, Korte KJ, Foa EB, Brady KT. Concurrent treatment of substance use disorders and PTSD using prolonged exposure: A randomized clinical trial in military veterans. Addict Behav. 2019 Mar; 90:369-377. PMID: 30529244.
      View in: PubMed
    7. Flanagan JC, Allan NP, Calhoun CD, Badour CL, Moran-Santa Maria M, Brady KT, Back SE. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder. Exp Clin Psychopharmacol. 2019 Feb; 27(1):45-54. PMID: 30382728.
      View in: PubMed
    8. Jarnecke AM, Allan NP, Badour CL, Flanagan JC, Killeen TK, Back SE. Substance use disorders and PTSD: Examining substance use, PTSD symptoms, and dropout following imaginal exposure. Addict Behav. 2019 Mar; 90:35-39. PMID: 30355535.
      View in: PubMed
    9. Jarnecke AM, Barden E, Back SE, Brady KT, Flanagan JC. Intimate partner violence moderates the association between oxytocin and reactivity to dyadic conflict among couples. Psychiatry Res. 2018 12; 270:404-411. PMID: 30308464.
      View in: PubMed
    10. Back SE, Flanagan JC, Jones JL, Augur I, Peterson AL, Young-McCaughan S, Shirley DW, Henschel A, Joseph JE, Litz BT, Hancock AK, Roache JD, Mintz J, Wachen JS, Keane TM, Brady KT. Doxazosin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in military veterans. Contemp Clin Trials. 2018 Oct; 73:8-15. PMID: 30145268.
      View in: PubMed
    11. Flanagan JC, Hand A, Jarnecke AM, Moran-Santa Maria MM, Brady KT, Joseph JE. Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder. Exp Clin Psychopharmacol. 2018 08; 26(4):391-402. PMID: 30070567.
      View in: PubMed
    12. Solomon DT, Nietert PJ, Calhoun C, Smith DW, Back SE, Barden E, Brady KT, Flanagan JC. Effects of Oxytocin on Emotional and Physiological Responses to Conflict in Couples with Substance Misuse. Couple Family Psychol. 2018 Jun; 7(2):91-102. PMID: 30740265.
      View in: PubMed
    13. Flanagan JC, Jones JL, Jarnecke AM, Back SE. Behavioral Treatments for Alcohol Use Disorder and Post-Traumatic Stress Disorder. Alcohol Res. 2018; 39(2):181-192. PMID: 31198657.
      View in: PubMed
    14. Flanagan JC, Sippel LM, Wahlquist A, Moran-Santa Maria MM, Back SE. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial. J Psychiatr Res. 2018 03; 98:64-69. PMID: 29294429.
      View in: PubMed
    15. Flanagan JC, Fischer MS, Nietert PJ, Back SE, Maria MM, Snead A, Brady KT. Effects of oxytocin on cortisol reactivity and conflict resolution behaviors among couples with substance misuse. Psychiatry Res. 2018 02; 260:346-352. PMID: 29232576.
      View in: PubMed
    16. Bountress KE, Badour C, Flanagan J, Gilmore AK, Back SE. Treatment of co-occurring posttraumatic stress disorder and substance use: Does order of onset influence outcomes? Psychol Trauma. 2018 Nov; 10(6):662-665. PMID: 28771018.
      View in: PubMed
    17. Flanagan JC, Fischer MS, Badour CL, Ornan G, Killeen TK, Back SE. The Role of Relationship Adjustment in an Integrated Individual Treatment for PTSD and Substance Use Disorders Among Veterans: An Exploratory Study. J Dual Diagn. 2017 Jul-Sep; 13(3):213-218. PMID: 28541802.
      View in: PubMed
    18. Szafranski DD, Snead A, Allan NP, Gros DF, Killeen T, Flanagan J, Pericot-Valverde I, Back SE. Integrated, exposure-based treatment for PTSD and comorbid substance use disorders: Predictors of treatment dropout. Addict Behav. 2017 10; 73:30-35. PMID: 28460246.
      View in: PubMed
    19. Badour CL, Flanagan JC, Gros DF, Killeen T, Pericot-Valverde I, Korte KJ, Allan NP, Back SE. Habituation of distress and craving during treatment as predictors of change in PTSD symptoms and substance use severity. J Consult Clin Psychol. 2017 Mar; 85(3):274-281. PMID: 28221062.
      View in: PubMed
    20. Gros DF, Flanagan JC, Korte KJ, Mills AC, Brady KT, Back SE. Relations among social support, PTSD symptoms, and substance use in veterans. Psychol Addict Behav. 2016 Nov; 30(7):764-770. PMID: 27786511.
      View in: PubMed
    21. Flanagan JC, Korte KJ, Killeen TK, Back SE. Concurrent Treatment of Substance Use and PTSD. Curr Psychiatry Rep. 2016 08; 18(8):70. PMID: 27278509.
      View in: PubMed
    22. Adams ZW, McCauley JL, Back SE, Flanagan JC, Hanson RF, Killeen TK, Danielson CK. Clinician Perspectives on Treating Adolescents with Co-occurring Post-Traumatic Stress Disorder, Substance Use, and Other Problems. J Child Adolesc Subst Abuse. 2016; 25(6):575-583. PMID: 27840568.
      View in: PubMed
    23. Flanagan JC, Hakes JK, McClure EA, Snead AL, Back SE. Effects of intimate partner violence, PTSD, and alcohol use on cigarette smoking in a nationally representative sample. Am J Addict. 2016 06; 25(4):283-90. PMID: 27196699.
      View in: PubMed
    24. Sullivan TP, Weiss NH, Flanagan JC, Willie TC, Armeli S, Tennen H. PTSD and Daily Co-Occurrence of Drug and Alcohol Use Among Women Experiencing Intimate Partner Violence. J Dual Diagn. 2016; 12(1):36-42. PMID: 26828635.
      View in: PubMed
    25. Forbes MK, Flanagan JC, Barrett EL, Crome E, Baillie AJ, Mills KL, Teesson M. Smoking, posttraumatic stress disorder, and alcohol use disorders in a nationally representative sample of Australian men and women. Drug Alcohol Depend. 2015 Nov 01; 156:176-183. PMID: 26386825.
      View in: PubMed
    26. Back SE, Gros DF, Price M, LaRowe S, Flanagan J, Brady KT, Davis C, Jaconis M, McCauley JL. Laboratory-induced stress and craving among individuals with prescription opioid dependence. Drug Alcohol Depend. 2015 Oct 01; 155:60-7. PMID: 26342626.
      View in: PubMed
    27. Sullivan TP, Flanagan JC, Dudley DN, Holt LJ, Mazure CM, McKee SA. Correlates of smoking status among women experiencing intimate partner violence: Substance use, posttraumatic stress, and coping. Am J Addict. 2015 Sep; 24(6):546-53. PMID: 26249027.
      View in: PubMed
    28. Flanagan JC, Baker NL, McRae-Clark AL, Brady KT, Moran-Santa Maria MM. Effects of adverse childhood experiences on the association between intranasal oxytocin and social stress reactivity among individuals with cocaine dependence. Psychiatry Res. 2015 Sep 30; 229(1-2):94-100. PMID: 26231584.
      View in: PubMed
    29. Jobe-Shields L, Flanagan JC, Killeen T, Back SE. Family composition and symptom severity among Veterans with comorbid PTSD and substance use disorders. Addict Behav. 2015 Nov; 50:117-23. PMID: 26132535.
      View in: PubMed
    30. Flanagan JC, Barrett EL, Crome E, Forbes M. Developing International Collaborations for Early Career Researchers in Psychology. Behav Ther (N Y N Y). 2015 Jun; 38(5):131-134. PMID: 27453624.
      View in: PubMed
    31. Flanagan JC, Gordon KC, Moore TM, Stuart GL. Women's Stress, Depression, and Relationship Adjustment Profiles as They Relate to Intimate Partner Violence and Mental Health During Pregnancy and Postpartum. Psychol Violence. 2015 Jan; 5(1):66-73. PMID: 25642352.
      View in: PubMed
    32. Moran-Santa Maria MM, Flanagan J, Brady K. Ovarian hormones and drug abuse. Curr Psychiatry Rep. 2014 Nov; 16(11):511. PMID: 25224609.
      View in: PubMed
    33. Jaquier V, Flanagan JC, Sullivan TP. Anxiety and posttraumatic stress symptom pathways to substance use problems among community women experiencing intimate partner violence. Anxiety Stress Coping. 2015; 28(4):445-55. PMID: 25251694.
      View in: PubMed
    34. Flanagan JC, Jaquier V, Overstreet N, Swan SC, Sullivan TP. The mediating role of avoidance coping between intimate partner violence (IPV) victimization, mental health, and substance abuse among women experiencing bidirectional IPV. Psychiatry Res. 2014 Dec 15; 220(1-2):391-6. PMID: 25174851.
      View in: PubMed
    35. Flanagan JC. Of women seeking assistance for intimate partner violence, those who report victimisation during pregnancy are at higher risk of further victimisation. Evid Based Nurs. 2015 Apr; 18(2):38. PMID: 25056870.
      View in: PubMed
    36. Back SE, Gros DF, McCauley JL, Flanagan JC, Cox E, Barth KS, Brady KT. Laboratory-induced cue reactivity among individuals with prescription opioid dependence. Addict Behav. 2014 Aug; 39(8):1217-23. PMID: 24813546.
      View in: PubMed
    37. Flanagan JC, Teer A, Beylotte FM, Killeen TK, Back SE. Correlates of Recent and Lifetime Aggression among Veterans with Co-Occurring PTSD and Substance Use Disorders. Ment Health Subst Use. 2014; 7(4):315-328. PMID: 25419233.
      View in: PubMed
    Flanagan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _